Literature DB >> 18303966

Ethnic variation of thiopurine S-methyltransferase activity: a large, prospective population study.

Sheldon C Cooper1, Loretta T Ford, Jonathan D Berg, Matthew J V Lewis.   

Abstract

UNLABELLED: The use of azathioprine (and its metabolite mercaptopurine) is limited by toxicity, especially myelosuppression, which is related to activity of the enzyme thiopurine S-methyltransferase (TPMT). TPMT activity varies between individuals and is considered deficient in one in 300 cases. AIMS &
METHODS: We identified TPMT activity within an ethnically diverse population of patients attending an inner-city hospital phlebotomy service. A total of 1000 subjects were recruited and analyzed with respect to age, sex and ethnicity.
RESULTS: Samples were analyzed from 456 Caucasians, 342 South Asians and 180 Afro-Caribbeans. Six subjects had deficient TPMT activity (0.6%: four women, two men; four Caucasians, one Afro-Caribbean, one South Asian). TPMT activity (nmol 6-methylthioguanine (6-MTG)/gHb/h) ranged 0-76 (median [interquartile range]: 33 [28-39]). Enzyme activity was lower in Afro-Caribbeans (30 [25-37.5]) than Caucasians (34 [29-40]) and South Asians (33 [29-38]), which was significant after adjustment for age and sex (p < 0.0001). Activity was lower in women (p = 0.022), especially South Asian females (n = 194; 32 [28-36]), compared with (35 [30-40]) in men (n = 148; p = 0.002).
CONCLUSIONS: A higher prevalence of TPMT deficiency was recorded than in previous studies. Afro-Caribbeans have lower activity than Caucasians and South Asians. TPMT enzyme activity was lower among females, especially in South Asians.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18303966     DOI: 10.2217/14622416.9.3.303

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  12 in total

Review 1.  The role of pharmacogenetics in nonmalignant gastrointestinal diseases.

Authors:  Michael Camilleri
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-07       Impact factor: 46.802

2.  Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.

Authors:  Jun J Yang; Wendy Landier; Wenjian Yang; Chengcheng Liu; Lindsey Hageman; Cheng Cheng; Deqing Pei; Yanjun Chen; Kristine R Crews; Nancy Kornegay; F Lennie Wong; William E Evans; Ching-Hon Pui; Smita Bhatia; Mary V Relling
Journal:  J Clin Oncol       Date:  2015-01-26       Impact factor: 44.544

3.  NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine.

Authors:  Nicholas C K Valerie; Anna Hagenkort; Brent D G Page; Geoffrey Masuyer; Daniel Rehling; Megan Carter; Luka Bevc; Patrick Herr; Evert Homan; Nina G Sheppard; Pål Stenmark; Ann-Sofie Jemth; Thomas Helleday
Journal:  Cancer Res       Date:  2016-08-16       Impact factor: 12.701

4.  Clinical predictors of thiopurine-related adverse events in Crohn's disease.

Authors:  Gordon W Moran; Marie-France Dubeau; Gilaad G Kaplan; Hong Yang; Bertus Eksteen; Subrata Ghosh; Remo Panaccione
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 5.  Disparities in cancer outcomes: lessons learned from children with cancer.

Authors:  Smita Bhatia
Journal:  Pediatr Blood Cancer       Date:  2011-02-15       Impact factor: 3.167

6.  Azathioprine does not reduce adenoma formation in a mouse model of sporadic intestinal tumorigenesis.

Authors:  Mattheus C B Wielenga; Jooske F van Lidth de Jeude; Sanne L Rosekrans; Alon D Levin; Monique Schukking; Geert R A M D'Haens; Jarom Heijmans; Marnix Jansen; Vanesa Muncan; Gijs R van den Brink
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 7.  Drug monitoring in systemic lupus erythematosus.

Authors:  Michelle Petri
Journal:  Curr Opin Pharmacol       Date:  2022-04-28       Impact factor: 4.768

8.  Genomewide Approach Validates Thiopurine Methyltransferase Activity Is a Monogenic Pharmacogenomic Trait.

Authors:  C Liu; W Yang; D Pei; C Cheng; C Smith; W Landier; L Hageman; Y Chen; J J Yang; K R Crews; N Kornegay; S E Karol; F L Wong; S Jeha; J T Sandlund; R C Ribeiro; J E Rubnitz; M L Metzger; C-H Pui; W E Evans; S Bhatia; M V Relling
Journal:  Clin Pharmacol Ther       Date:  2016-11-18       Impact factor: 6.875

9.  Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain.

Authors:  David Gurwitz; Cristina Rodríguez-Antona; Katherine Payne; William Newman; Javier P Gisbert; Emma Gutiérrez de Mesa; Dolores Ibarreta
Journal:  Eur J Hum Genet       Date:  2009-02-18       Impact factor: 4.246

10.  Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?

Authors:  Hong Zhou; Lei Li; Peng Yang; Lin Yang; Jin E Zheng; Ying Zhou; Yong Han
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.